South Korea considers Poison Pills

13 November 2009

Sarah Wilson

EU regulation

The Korean Justice Ministry stated this week that Korea has 'made hostile M&A attacks easy by removing a ceiling on foreign stock investments, but it has not had any means to prevent hostile M&A'. It has announced public hearings to consider proposals to provide for the use of poison pills. Reuters reported that business groups have called for a clause to allow an acquisition target to issue new shares to designated shareholders at a preset low price, thus diluting the ownership value for a hostile bidder.

Further Reading

South Korea Considers Letting Companies Use Poison Pills

Latest News

SHareholder meeting

Texas Launches Fresh Proxy Advisor Lawsuit

SHareholder meeting

Shareholders Challenge Nike on Emissions Reduction Efforts

SHareholder meeting

The EU’s New Sustainability Regulations for Non-EU Companies Highlights a Growing Divide

SHareholder meeting

Investors Rights Group Urges SEC to Avoid Dismantling Rule 14a-8

SHareholder meeting

Texas Presses FTC, Attorney General on Anti-proxy Advisor Action

SHareholder meeting

Minerva Analytics Backs FRC Revisions to UK Audit and Assurance Standards

Featured Briefings

Minerva Briefing

UK Proxy Season Review 2026

Minerva Briefing

Australia Proxy Season Review 2025

Minerva Briefing

2026 Proxy Season Preview

Related Stories

No items found.